🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MLS101 is being developed as a low dose psilocybin, that can be administere...
Status
Completed
Location
CMAX Clinical Research
Start Date
2024-11-08
Trial ID
NCT06643637
Treatments Being Tested
Psilocybin is a classic serotonergic hallucinogen acting on the 5-HT2A rece...
Status
Completed
Location
University Hospital Basel, Clinical Trial Unit
Start Date
2019-07-04
Trial ID
NCT03912974
Treatments Being Tested
The PEARL Pilot is a phase II open-label trial. Participants will receive a...
Status
Active Not Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2024-06-06
Trial ID
NCT06416085
Treatments Being Tested
The purpose of this research study is to compare an oral dose of psilocybin...
Status
Withdrawn
Location
University of Wisconsin
Start Date
2023-06
Trial ID
NCT05467761
Treatments Being Tested
The goal of this clinical trial is to learn whether certain methods of dete...
Status
Unknown
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06529939
Treatments Being Tested
The primary aim of this study is to assess the safety and tolerability of o...
Status
Completed
Location
Altman Clinical and Translational Research Institute
Start Date
2021-05-01
Trial ID
NCT04661514
Treatments Being Tested
The purpose of the present study is to evaluate the feasibility, initial si...
Status
Withdrawn
Location
University of Alabama at Birmingham
Start Date
2023-08-15
Trial ID
NCT05227742
Treatments Being Tested
The purpose of this research study is to investigate the safety and feasibi...
Status
Terminated
Location
University of Wisconsin
Start Date
2023-03-03
Trial ID
NCT05322954
Treatments Being Tested
This study will examine the safety and preliminary efficacy of psilocybin m...
Status
Active Not Recruiting
Location
Scottsdale Research Institute
Start Date
2026-03-20
Trial ID
NCT07275970
Treatments Being Tested
The primary objective of the study is to evaluate the safety and efficacy o...
Status
Completed
Location
University of Chicago
Start Date
2023-11-01
Trial ID
NCT05399498
Treatments Being Tested